Glucose catabolism in cancer cells - Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions
Sp. Mathupala et al., Glucose catabolism in cancer cells - Identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions, J BIOL CHEM, 276(46), 2001, pp. 43407-43412
One of the most common signatures of highly malignant tumors is their capac
ity to metabolize more glucose to lactic acid than their tissues of origin.
Hepatomas exhibiting this phenotype are dependent on the high expression o
f type Il hexokinase, which supplies such tumors with abundant amounts of g
lucose 6-phosphate, a significant carbon and energy source especially under
hypoxic conditions. Here we report that the distal region of the hepatoma.
type Il hexokinase promoter displays consensus motifs for hypoxia-inducibl
e factor (HIF-1) that overlap E-box sequences known to be related in other
gene promoters to glucose response. Moreover, we show that subjecting trans
fected hepatoma cells to hypoxic conditions activates the type II hexokinas
e promoter almost 3-fold, a value that approaches 7-fold in the presence of
glucose. Consistent with these findings is the induction under hypoxic con
ditions of the HIF-1 protein. Reporter gene analyses with a series of neste
d deletion mutants of the hepatoma type II hexokinase promoter show that a
significant fraction of the total activation observed under hypoxic conditi
ons localizes to the distal region where the overlapping HIF-1/E-box sequen
ces are located. Finally, DNase I footprint analysis with a segment of the
promoter containing these elements reveals the binding of several nuclear p
roteins. In summary, these novel studies identify and characterize a marked
glucose-modulated activation response of the type II hexokinase gene to hy
poxic conditions within highly glycolytic hepatoma cells, a property that m
ay help assure that such cells exhibit a growth and survival advantage over
their parental cells of origin.